Trial Profile
A randomized phase II trial of tivozanib in combination with FOLFOX in patients with NRP-1 low colorectal cancer
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 15 Jun 2015
Price :
$35
*
At a glance
- Drugs Tivozanib (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 15 Jun 2015 Trial focus assumed.
- 15 Jun 2015 New trial record